• 120 years of KNCV

    27/09/2023

    KNCV TB Plus celebrates 120 years: A legacy of fighting TB

    Today, we proudly celebrate the 120th anniversary of KNCV TB Plus, an organization with an enduring commitment to eradicating the…

    Lees meer

  • 25/09/2023

    Historic Political Declaration on TB adopted by Member States at the UN High-Level Meeting on TB

    KNCV Tuberculosis Foundation welcomes the Political Declaration, formally adopted by United Nations Member States, of the High-Level Meeting (HLM)…

    Lees meer

  • 16/08/2023

    Video: Striving Towards a World Free of TB and Improving Global Health

    In Juli 2023, Reuters, a multimedia news provider, published a news item and…

    Lees meer

  • 03/08/2023

    Stigma Reduction Intervention for HCWs webinar: Introduction to Allies Approach

    You are invited to the Stigma Reduction Intervention for HCWs webinar: Introduction to Allies Approach.The Allies Approach is designed as…

    Lees meer
  • Man met ezel

    21/07/2023

    New study: Without TB prevention, tuberculosis will result in close to 1 million deaths by 2035

    Combination intervention found to be cost-effective in averting illness and deaths in high-risk groups People living in close…

    Lees meer

  • 30/06/2023

    A poem about tuberculosis: ‘The silent battles you fought’

    This poem was written by Kinjal Sanghavi, a talented poetess from India. One of her close friends fell ill with…

    Lees meer

  • 29/06/2023

    KNCV Annual Report 2022 presented to Her Royal Highness Princess Margriet

    Executive Director of KNCV Tuberculosis Foundation, Dr. Gidado Mustapha, presented the 2022 annual report to Her Royal Highness (HRH)…

    Lees meer

  • 28/06/2023

    Reimagining Emily Brontë’s state of mind dying of tuberculosis

    It has almost been 175 years since Emily Brontë, the English novelist best known for ‘Wuthering Heights’, died of tuberculosis…

    Lees meer

  • 17/05/2023

    Saying goodbye and welcoming: two long esteemed colleagues

    Today we are saying goodbye to Jan Hendrik Richardus, Vice-Chair of the Board of Trustees (BoT) of…

    Lees meer

  • 06/04/2023

    Investing in TB vaccine research and development can save millions of lives

    Despite progress in TB control efforts, the global burden of TB remains high, with an estimated 10.6 million new cases…

    Lees meer

  • 04/04/2023

    Join us for a Round Table Discussion on BPaLM/BPaL

    On 12 April 2023, KNCV TB Plus will conduct an online Round Table Discussion on ‘Experience sharing: Preparation for programmatic…

    Lees meer

  • 30/03/2023

    KNCV Ethiopia’s Contributions and Recognition during the 17th Annual TB Research Conference (TRAC)

    KNCV TB Plus Ethiopia participated in 17th annual tuberculosis (TB) research conference (TRAC) and in the World TB Day commemoration, which…

    Lees meer

  • 24/03/2023

    250,000 patients to benefit from free access to short-course TB preventive treatment across seven countries

    Johannesburg, 24 March 2023 – The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will…

    Lees meer

  • 24/03/2023

    Technical Brief: 5 Country Experiences with Digital Adherence Technologies

    Today is World TB Day, with Yes, We Can End TB as the theme for 2023. Digital Adherence Technologies (DATs)…

    Lees meer

  • 24/03/2023

    Why the world needs to start managing TB as a healthcare crisis

    by Mustapha Gidado, Executive Director, KNCV TB Plus. Increased political will and financial investment — plus the…

    Lees meer
Bezoek Nederlandse website

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Cambodia
Eswatini
Ethiopia
Indonesia
Kazakhstan
Kenya
Kyrgyzstan
Namibia
Nigeria
Tajikistan
Tanzania
Ukraine
Vietnam
Zambia

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

KNCV’s Technical Assistance Strategy

New drugs & treatment regimens
BPaL implementation
Digital health solutions
Diagnosis & treatment of LTBI
TB Stigma reduction
Epidemiological measurement methodologies
New diagnostics and lab network design
People-Centred Framework for National Strategic Planning and HSS
Blended learning platform & methodologies

Current Projects

ASCENT
ASTTIE
ETBE Project
Evaluation of SeroSelectTB
GeneXpert MTB/RIF Test
iDEFEAT TB Project
IMPAACT4C19
IMPAACT4TB
LIFT-TB 
No More Pandemics
PANGenS
People-Centered Framework for TB Programming (PCF)
Triage Test for All Oral DR TB Regimen (TriAD)
SMART4TB
The Global Fund to Fight AIDS, Tuberculosis and Malaria

Completed Projects

Challenge TB
Development of a comprehensive Digital Training Package
E-detect
Improved TB/HIV Prevention & Care – Building Models for the Future Project
PAVIA
PODTEC
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania
TREATS

KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers
KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs
KNCV Webinar ‘Infection prevention and control for COVID-19

Annual Reports
KNCV 2-pager ASCENT
KNCV 2-pager Childhood TB
KNCV 2-pager Digital Health
KNCV 2-pager General
KNCV 2pager Right Diagnosis, Right Treatment
KNCV 2-pager TB Photovoices
KNCV 2-pager TB Stigma

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.